Drug Approval | June 16, 2023
Briefs: Natco Pharma and Panacea Biotec
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
Panacea Biotec has announced the launch of its new range of high-quality pediatric food & nutritional products
The OAI classification implies that the USFDA expects further corrective actions and may withhold approval of any pending product applications or supplements filed from this facility till the outstanding observations are resolved
Mankind Pharma has agreed to retain Panacea Biotec’s sales and marketing team engaged in this business
The pharma division’s domestic business generated turnover of Rs. 219.85 crore for the last financial year
Subscribe To Our Newsletter & Stay Updated
